Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes.
Joana Simões-PereiraAna SaramagoRicardo RodriguesMarta PojoCarolina PiresMariana HortaDolores López-PresaMiguel RitoRafael CabreraTeresa C FerreiraValeriano LeiteBranca Maria CavacoPublished in: Endocrine (2023)
Early identification of molecular markers in primary tumours may help to predict RAI therapy avidity, the response of metastatic lesions and to select the patients that may benefit the most from other systemic therapies.
Keyphrases
- papillary thyroid
- lymph node metastasis
- squamous cell carcinoma
- end stage renal disease
- small cell lung cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- stem cells
- metabolic syndrome
- patient reported outcomes
- insulin resistance
- young adults
- skeletal muscle
- childhood cancer
- replacement therapy